Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sources

Deutschland Nachrichten Nachrichten

Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sources
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 Reuters
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 97%

Exclusive: The trial for a vaccine being developed by AstraZeneca and Oxford University remains on hold in the U.S. pending an investigation into a serious side effect in Britain

CHICAGO - AstraZeneca’s COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.

AstraZeneca on Saturday said it had restarted its trial in Britain after regulators completed their review of a serious side effect in one trial participant there. Enrollment in the company’s global trials of the vaccine, which it is developing with researchers at Oxford University, was put on pause on Sept. 6.

Governments around the world are desperate for a vaccine to help end the pandemic, which has caused more than 900,000 deaths and global economic turmoil. The World Health Organization had flagged AstraZeneca’s as the most promising. A prolonged delay in the U.S. trial could slow access to the vaccine in the United States.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Reuters /  🏆 2. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

AstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illnessAstraZeneca resumes UK trials of COVID-19 vaccine halted by patient illnessAstraZeneca has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday.
Weiterlesen »

Pfizer, BioNTech propose expanding COVID-19 vaccine trial to 44,000 volunteersPfizer, BioNTech propose expanding COVID-19 vaccine trial to 44,000 volunteersPfizer Inc and BioNTech SE on Saturday proposed to the U.S Food and Drug Administration (FDA) to expand their Phase 3 pivotal COVID-19 vaccine trial to about 44,000 participants while increasing the diversity of the trial population.
Weiterlesen »

Inside the life of an Uber driver in NYC during COVID-19 - Business InsiderInside the life of an Uber driver in NYC during COVID-19 - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Weiterlesen »

When will there be a COVID-19 vaccine and should you trust that it's safe?When will there be a COVID-19 vaccine and should you trust that it's safe?Americans want a COVID-19 vaccine—but worry that it could be rushed out before the election. Here's what the science says.
Weiterlesen »

HHS Officials Altered CDC COVID-19 Reports to Help TrumpHHS Officials Altered CDC COVID-19 Reports to Help TrumpTrump-appointed officials have been interfering to protect the president’s deliberately misleading COVID-19 spin.
Weiterlesen »



Render Time: 2025-03-11 04:15:21